CellaVision AB (publ) (OTCMKTS:CLVSF) Stock Price Up 1.8% – Should You Buy?

CellaVision AB (publ) (OTCMKTS:CLVSF) was up 1.8% during mid-day trading on Thursday . The stock traded as high as $17.30 and last traded at $17.30. Approximately 400 shares changed hands during mid-day trading, an increase of 60% from the average daily volume of 250 shares. The stock had previously closed at $17.00.

CellaVision AB (publ) Stock Up 1.8%

The firm has a 50 day moving average price of $16.89 and a 200-day moving average price of $18.38.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.